Browsing Tag
autologous cell therapy
2 posts
ProKidney (NASDAQ: PROK) stock surges over 22% after Phase 2 REGEN-007 trial shows strong kidney function stabilization
Find out why ProKidney stock soared 22% after new Phase 2 data on rilparencel in chronic kidney disease patients. Analysts see potential FDA fast-track.
GC Cell forms strategic partnership with Bifarma to expand cell therapy in Indonesia
GC Cell, a leader in cell and gene therapy, has announced a strategic partnership with Bifarma, a prominent…